Search hospitals > New York > Bronx
Albert Einstein Comprehensive Cancer Center
Claim this profileBronx, New York 10461
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Adult T-Cell Leukemia/Lymphoma
Conducts research for Lymphoma
Conducts research for Leukemia
225 reported clinical trials
5 medical researchers
Summary
Albert Einstein Comprehensive Cancer Center is a medical facility located in Bronx, New York. This center is recognized for care of Cancer, Breast Cancer, Adult T-Cell Leukemia/Lymphoma, Lymphoma, Leukemia and other specialties. Albert Einstein Comprehensive Cancer Center is involved with conducting 225 clinical trials across 162 conditions. There are 5 research doctors associated with this hospital, such as Sanjay Goel, Ioannis Mantzaris, MD, Beth N. Mclellan, MD, and Anna Ferrari, MD.Area of expertise
1Cancer
Global LeaderStage IV
HER2 positive
Stage III
2Breast Cancer
Global LeaderStage IV
HR
HER2
Top PIs
Sanjay GoelMontefiore Medical Center5 years of reported clinical research
Expert in Solid Tumors
Expert in Cancer
21 reported clinical trials
30 drugs studied
Ioannis Mantzaris, MDMontefiore Medical Center - Moses Campus2 years of reported clinical research
Studies Adult T-Cell Leukemia/Lymphoma
Studies Myeloid Leukemia
10 reported clinical trials
27 drugs studied
Beth N. Mclellan, MDMontefiore Einstein Center for Cancer Care5 years of reported clinical research
Studies Palmar-Plantar Erythrodysesthesia
1 reported clinical trial
2 drugs studied
Anna Ferrari, MDMontefiore Einstein Center for Cancer Care5 years of reported clinical research
Studies Prostate Cancer
1 reported clinical trial
3 drugs studied
Clinical Trials running at Albert Einstein Comprehensive Cancer Center
Solid Tumors
Small Cell Lung Cancer
Myelodysplastic Syndrome
Myelofibrosis
Cancer
Lung Cancer
Adult T-Cell Leukemia/Lymphoma
Myeloid Leukemia
Acute Myelogenous Leukemia
Myelodysplastic syndrome
DF1001
for Solid Cancers
This trial is testing a new treatment called DF1001-001 that helps the immune system target and destroy cancer cells. It focuses on patients with certain types of cancers that have a protein called HER2. The treatment works by activating immune cells to recognize and attack these cancer cells.
Recruiting1 award Phase 1 & 252 criteria
Targeted Therapy + Immunotherapy
for Advanced Cancer
TAPISTRY is a Phase II, global, multicenter, open-label, multi-cohort study designed to evaluate the safety and efficacy of targeted therapies or immunotherapy as single agents or in rational, specified combinations in participants with unresectable, locally advanced or metastatic solid tumors determined to harbor specific oncogenic genomic alterations or who are tumor mutational burden (TMB)-high as identified by a validated next-generation sequencing (NGS) assay. Participants with solid tumors will be treated with a drug or drug regimen tailored to their NGS assay results at screening. Participants will be assigned to the appropriate cohort based on their genetic alteration(s). Treatment will be assigned on the basis of relevant oncogenotype, will have cohort-specific inclusion/exclusion criteria, and, unless otherwise specified, will continue until disease progression, loss of clinical benefit, unacceptable toxicity, participant or physician decision to discontinue, or death, whichever occurs first.
Recruiting1 award Phase 212 criteria
AN4005
for Advanced Cancer
This trial tests a new drug, AN4005, in patients with advanced tumors. It aims to find the highest safe dose by adjusting the amount given over time.
Recruiting1 award Phase 110 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Albert Einstein Comprehensive Cancer Center?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.